Cayenne

What is Cayenne?

Cayenne is the dried ripe fruit of Capsicum annuum, and European Pharmacopoeia monograph 1859 requires at least 0.4 percent total capsaicinoids, but that monograph covers only Capsicum annuum var. minimum and small-fruited Capsicum frutescens, and requires that fruits of the long-fruited var. longum, the cayenne type, be absent. That specification separates a drug ingredient from a spice, and almost nothing sold as a cayenne supplement in the United States is held to it.

Capsicum was cultivated in the Americas for roughly 7,000 years before Columbus carried it to Europe around 1493, and “cayenne” traces to the Old Tupi word kyynha. Cayenne-type fruits are long and tapering, commonly 10 to 25 cm, and most named cultivars fall between 30,000 and 50,000 Scoville Heat Units.

The chemistry happens in a small part of the fruit. Capsaicinoids are made in the placental tissue, the pale internal partition the seeds attach to, where ripe fruit carries about 64 mg per g dry weight against about 7 mg per g in the pericarp and 5 mg per g in the seeds. Biosynthetic enzyme activity peaks at 28 to 35 days after fruit set, and the pathway runs from phenylalanine through PAL, C4H, C3H and CAOMT, with the Pun1 locus encoding the acyltransferase AT3.

Cayenne is therefore a food, a pharmacopeial drug substance, a prescription product and a riot-control agent, all from one molecule at different concentrations. Capsaicin was isolated by John Clough Thresh in 1876 and synthesized in 1930.

Common Names

• Cayenne pepper, cayenne
• Capsicum, capsicum fruit, Capsici fructus
• Red pepper, ground red pepper
• African bird pepper, Guinea pepper
• Capsicum oleoresin, oleoresin capsicum, OC

Primary Active Compounds

• Capsaicin, C18H27NO3, molar mass 305.4 g/mol, CAS 404-86-4, melting point 62 to 65 degrees C, water solubility 0.0013 g per 100 mL. Roughly 69 percent of total capsaicinoids.
• Dihydrocapsaicin, roughly 22 percent, equal to capsaicin in pungency at 16,000,000 SHU.
• Nordihydrocapsaicin, roughly 7 percent, rated 9,100,000 SHU.
• Homocapsaicin and homodihydrocapsaicin, roughly 1 percent each, rated 8,600,000 SHU.
• Nonivamide, a minor natural capsaicinoid also made synthetically, capped at 5.0 percent of total capsaicinoids by USP and European Pharmacopoeia.
• Carotenoids, 393 micrograms beta-carotene and 237 micrograms lutein plus zeaxanthin per teaspoon of powder.

Key Note

The three capsaicinoids that AOAC Official Method 995.03 quantifies, nordihydrocapsaicin, capsaicin and dihydrocapsaicin, account for the large majority of a Capsicum fruit’s total capsaicinoid content. Every heat claim and every Scoville figure on a cayenne label is a rearrangement of those three numbers, and the rearrangement is where the information goes missing.

Cayenne is one of the few supplement ingredients whose standard potency number was designed to describe taste.

Primary Functions & Benefits

Cayenne does several unrelated things depending on whether the capsaicinoids reach a nerve ending in skin, a receptor in the gut wall, or the systemic circulation.

Topical analgesia by nerve defunctionalization

The best-supported function and the only one with a prescription product behind it. Repeated or high-concentration capsaicin first excites and then functionally silences TRPV1-expressing nociceptors, reducing epidermal nerve fiber density in the treated area. Qutenza, an 8 percent capsaicin topical system, was approved by FDA in 2009 for postherpetic neuralgia and in July 2020 for neuropathic pain of diabetic peripheral neuropathy of the feet.

Thermogenesis and modest appetite effects

Capsaicinoids activate TRPV1 on gut vagal afferents and sympathetic pathways. In a 12-week randomized trial by Urbina and colleagues in Appetite, 2017, 77 overweight adults took 2 mg or 4 mg of capsaicinoids daily or placebo. The 4 mg group ate 284 kcal per day less than baseline and 252 kcal per day less than placebo.

Lipid modification

Jiang and colleagues pooled nine randomized trials totaling 461 patients with metabolic syndrome in 2022. Total cholesterol fell by a weighted mean difference of 0.48 mmol/L (95 percent CI 0.63 to 0.34 lower) and LDL by 0.23 mmol/L (95 percent CI 0.45 to 0.02 lower). Doses ranged from 2 mg to 3,200 mg daily, which shows how loosely the literature defines a dose.

Gastric mucosal protection

Yeoh and colleagues, in Digestive Diseases and Sciences, 1995, gave 18 healthy volunteers 20 g of chili with 200 mL of water, then 600 mg of aspirin 30 minutes later. Median endoscopic gastric injury score was 1.5 after chili versus 4 in controls, p less than 0.05.

Functional dyspepsia symptom relief

Bortolotti and colleagues reported in Alimentary Pharmacology and Therapeutics, 2002, that red pepper powder taken daily for five weeks cut epigastric pain, fullness and nausea more than placebo, with the effect emerging in the third week.

Forms & Standardization

This is where the category separates into products that mean something and products that do not.

Ground dried fruit, capsules or bulk powder

The most common retail form, with capsule weights of 450 mg, 500 mg and 515 mg dominating. Potency is declared in heat units, typically 40,000 HU, 50,000 HU or 100,000 HU, and no milligram figure for capsaicinoids appears on the Supplement Facts panel. Ph. Eur. monograph 1859 requires minimum 0.4 percent total capsaicinoids, maximum 11.0 percent loss on drying and maximum 10.0 percent total ash, and a supplement sold as food is under no obligation to meet any of it.

Capsicum oleoresin

A concentrated solvent extract, far more consistent than powder. USP requires not less than 6.5 percent total capsaicinoids on an anhydrous basis. The European Pharmacopoeia monograph for refined and quantified capsicum oleoresin specifies 6.5 to 8.0 percent m/m expressed as capsaicin, maximum 8.0 percent water, and nonivamide at maximum 5.0 percent of total capsaicinoids.

Standardized fruit extract

Commercial extracts commonly declare 1.0 percent capsaicinoids. The EU herbal monograph recognizes a soft extract at drug-to-extract ratio 4 to 7 to 1 standardized to 2.0 to 2.78 percent total capsaicinoids in 80 percent ethanol, one at DER 1.5 to 2.5 to 1 in 96 percent ethanol, and one at DER 11 to 30 to 1 in propan-2-ol.

Over-the-counter topical

FDA regulates capsaicin and capsicum oleoresin as external analgesic actives. Retail creams run 0.025 percent to 0.075 percent capsaicin, applied three to five times daily. EU semi-solid preparations are specified at 40 to 53 mg capsaicinoids per 100 g.

Medicated plasters

The EU monograph adopted 5 May 2015, EMA/HMPC/674139/2013, specifies two plaster sizes: 11 mg capsaicinoids at 35 micrograms per cm2, and 4.8 mg at 22 micrograms per cm2. One plaster daily, worn 4 to 12 hours, at least 12 hours apart.

Prescription 8 percent patch

Qutenza carries 640 micrograms of capsaicin per cm2 across a 14 cm by 20 cm patch, 280 cm2, for 179 mg per patch. Up to four patches per treatment, 60 minutes for postherpetic neuralgia and 30 minutes for diabetic peripheral neuropathy of the feet, no more often than every 3 months. Defense sprays use the same oleoresin at weapon concentration, which shows that the difference between a spice and an incapacitant is dilution.

Food Sources

Cayenne is a spice, so the realistic food dose is small but not trivial.

What one teaspoon actually contains

One teaspoon of ground red or cayenne pepper weighs 1.8 g and supplies 5.7 kcal, 0.49 g fiber, 749 IU vitamin A, 393 micrograms beta-carotene, 113 micrograms beta-cryptoxanthin, 0.54 mg vitamin E, 1.4 mg vitamin C and 36 mg potassium. At a cayenne capsaicinoid content of 0.25 to 0.6 percent, that teaspoon carries roughly 4.5 to 11 mg of capsaicinoids, two to five times the 2 mg daily dose in the low-dose arm of the Urbina trial.

Where the capsaicinoids are in the whole fruit

The placental partition carries about ten times the capsaicinoid concentration of the pericarp or the seeds, which pick up surface capsaicinoids mainly by contact. Removing the pith removes most of the active fraction.

Other dietary sources

• Fresh cayenne and other hot Capsicum annuum fruits, 30,000 to 50,000 SHU for cayenne types
• Jalapeno, 2,500 to 10,000 SHU
• Chili powder blends, hot sauces, chili oils, paprika (non-pungent cultivars, essentially 0 SHU)
• Crushed red pepper flakes, which include placental material and often run hotter per gram than powder

What drying does

Drying concentrates capsaicinoids by removing water, so dried fruit reads hotter per gram than fresh fruit of the same cultivar. It does not create capsaicinoids, and comparing a dried powder’s SHU to a fresh pepper’s without adjusting for moisture is a standard way to exaggerate potency.

What cooking does

Less than people assume. Si and colleagues, in Natural Product Communications, 2014, held capsaicinoid solutions at 25, 65 and 100 degrees C for 90 minutes. At 100 degrees C, samples starting at 1,000 ppm retained above 95 percent and samples starting at 200 ppm retained above 70 percent, so degradation was proportionally worse at low starting concentrations. Capsaicin melts at 62 to 65 degrees C and dissolves at 0.0013 g per 100 mL of water, so in a pan it migrates into fat rather than breaking down.

Population intake

BfR estimates daily capsaicin intake at a maximum of 0.5 to 1.5 mg per person in Europe and the United States, against 25 to 200 mg per person in Thailand, Korea, India and Mexico. One teaspoon of cayenne puts a US eater into the middle of that gap.

Who Should Take Cayenne

Cayenne is a targeted ingredient with a small number of defensible uses.

• People with localized neuropathic pain. The strongest case, and it points to topical products rather than capsules. Postherpetic neuralgia and painful diabetic neuropathy of the feet have FDA-approved capsaicin treatment.
• People with osteoarthritis or musculoskeletal pain wanting a non-systemic option. Creams at 0.025 to 0.075 percent are cheap, sold without prescription, and carry no systemic drug burden.
• People with functional dyspepsia. The Bortolotti data support a trial of red pepper powder, with the caveat that symptoms often worsen in week one before improving around week three.
• People with metabolic syndrome already managing lipids. The 2022 meta-analysis of nine trials in 461 patients supports a small total cholesterol and LDL effect, not a replacement for anything.
• People eating a bland diet who want the food. In the China Kadoorie Biobank cohort of 487,375 adults, followed a median 7.2 years with 20,224 deaths, spicy food 6 to 7 days per week versus less than weekly carried an all-cause hazard ratio of 0.86 (95 percent CI 0.82 to 0.90). Observational, and about food rather than capsules.

Cayenne does not belong in a daily stack for someone with no pain, no dyspepsia and no lipid problem.

Who Should AVOID or Use Caution

Contraindications

• Known hypersensitivity to capsaicinoids or pepper plants. Anaphylaxis to Capsicum has been reported.
• Broken skin, open wounds, eczema or dermatitis at the application site, per the EU herbal monograph.
• Application near the eyes or mucous membranes.
• Active anal fissure. Gupta’s randomized, placebo-controlled, double-blind crossover trial in Arquivos de Gastroenterologia, 2008, gave 43 patients capsules of dried chili powder or placebo for one week each in crossover. Pain scored 2.05 on chili versus 0.97 on placebo and anal burning 1.85 versus 0.71, both significantly worse on chili. Of the patients, 81.3 percent preferred placebo.
• Cutaneous use under 18 years, which the EU monograph does not recommend.

Use Caution

• Active peptic ulcer, gastritis or reflux. The gastroprotection data come from single acute doses in healthy volunteers, not chronic use in damaged mucosa.
• Uncontrolled hypertension. The Qutenza label warns of transient blood pressure increases during and after application.
• Pregnancy and lactation. Cooper and Cooper reported in 1996 that two nursing infants developed erythematous dermatitis after their mothers ate red pepper-flavored foods.
• Transplant recipients on cyclosporine. Capsaicin can inhibit CYP3A and raise cyclosporine exposure.
• Anyone on an ACE inhibitor with a cough. Capsaicin is documented to initiate or worsen ACE inhibitor-induced cough.
• Handling raw or powdered cayenne bare-handed. “Hunan hand,” a contact dermatitis with burning lasting hours, is well described in pepper workers and home cooks.

Critical Safety Point

The 8 percent patch is not a stronger drugstore cream. Each Qutenza patch holds 179 mg of capsaicin, a clinician applies it, peak plasma concentration reaches about 4.6 ng/mL on removal, and reductions in sensory function require clinical assessment before each dose. None of that transfers to self-treatment with a hotter cream or capsule.

Recommended Dosages

Cayenne has no official daily intake, because it is a spice and a botanical drug substance rather than a nutrient. What follows is what trials have given people, and what the pharmacopeias specify.

Capsaicinoids, oral, metabolic and appetite endpoints: 2 mg to 6 mg per day of total capsaicinoids. The Urbina 2017 trial used 2 mg and 4 mg daily for 12 weeks in 77 subjects, and the 4 mg arm produced both the appetite effect and the gastrointestinal complaints.

Ground cayenne powder, oral, general use: 500 mg to 1,500 mg per day of dried fruit, split across two capsules with meals. At 0.25 to 0.6 percent capsaicinoids that is roughly 1.3 mg to 9 mg of capsaicinoids.

Red pepper powder, functional dyspepsia: approximately 2.5 g per day divided across meals for five weeks.

Capsicum oleoresin: dosed by capsaicinoid content, not oleoresin weight. At the USP floor of 6.5 percent, 50 mg of oleoresin supplies about 3.3 mg of capsaicinoids.

Topical cream, OTC: 0.025 percent to 0.075 percent capsaicin, three to five times daily.

Medicated plaster, EU specification: one plaster daily supplying either 11 mg capsaicinoids at 35 micrograms per cm2 or 4.8 mg at 22 micrograms per cm2, worn 4 to 12 hours.

Prescription 8 percent patch: up to four patches, 60 minutes for postherpetic neuralgia or 30 minutes for diabetic peripheral neuropathy of the feet, every 3 months at most.

Duration

For cutaneous herbal preparations the EU monograph draws a clear line: continue until pain relief is achieved, if necessary up to 3 weeks, then break for at least 2 weeks. For oral capsaicinoids the longest well-controlled trial ran 12 weeks, and no controlled human data exist past that point, so continuous year-round use is an extrapolation rather than a protocol.

Timing & Administration

Take oral cayenne with food. Roughly 50 to 90 percent of an oral dose is absorbed passively, peaking about 1 hour after intake. An empty stomach does not improve absorption and sharply raises the odds of epigastric burning.

Split the dose. Two doses of 250 to 500 mg across meals are tolerated better than one larger dose, and the trials reporting appetite effects dosed before meals. For dyspepsia, expect a bad first week: improvement over placebo appeared around week three.

For topical creams, frequency beats strength. Three to five applications daily for two to four weeks produces defunctionalization. A 0.075 percent cream once a day is a weaker intervention than a 0.025 percent cream four times a day.

Wear gloves, and wash with oil rather than water. Capsaicin’s water solubility is 0.0013 g per 100 mL, so soap and water move it around while cooking oil, milk fat or rubbing alcohol dissolve it. Residual capsaicin on fingers transfers readily to eyes and lips for hours afterward.

Do not apply heat over a topical capsaicin product. The EU monograph warns against additional heat sources during treatment. Heating pads, hot baths and saunas can turn a tolerable burn into a chemical injury.

Timeline of Effects

Seconds to minutes, topical or oral: the burn. TRPV1 opens, calcium enters the nociceptor, and the sensation begins. This is the pharmacology working, not a side effect.

20 to 60 minutes, oral: peak plasma concentration, with thermogenic and satiety effects measurable in the acute-feeding studies that found them.

1 to 3 hours, oral: the burn subsides and gastric warmth resolves in most people.

2 to 7 days, topical low-concentration cream: burning declines as local substance P depletes and nociceptors desensitize. Most people abandon the cream during this window.

2 to 4 weeks, topical: the analgesic effect of 0.025 to 0.075 percent creams, where it occurs, is established by this point with three-to-five-times-daily use.

Week 1 to week 3, oral for dyspepsia: symptoms often worsen before improving, with separation from placebo in the third week.

1 week to 12 weeks, single 8 percent patch: Qutenza’s effect builds over the first week after application and is dosed on a 3-month cycle, reflecting how long axonal reinnervation takes.

12 weeks, oral capsaicinoids for body composition: the Urbina trial found reduced caloric intake but no significant change in fat mass (p equal to 0.92 for the treatment effect). Twelve weeks of 4 mg daily did not produce fat loss.

Benefits of Taking Cayenne

Neuropathic pain reduction that survived blinded trials. Backonja and colleagues randomized 402 patients with postherpetic neuralgia in The Lancet Neurology, 2008, to a single 60-minute application of the 8 percent patch or a 0.04 percent control. Mean pain score change over weeks 2 to 8 was minus 29.6 percent versus minus 19.9 percent, p equal to 0.001, and 42 percent of treated patients achieved at least a 30 percent reduction versus 32 percent of controls.

Cholesterol reduction in metabolic syndrome. Total cholesterol down 0.48 mmol/L and LDL down 0.23 mmol/L across nine trials in 461 patients.

Reduced caloric intake, 252 kcal per day below placebo at 4 mg daily, and acute protection against aspirin-induced gastric injury, median injury score 1.5 versus 4 in 18 volunteers.

An inverse association with mortality at population scale. In 487,375 Chinese adults, all-cause hazard ratio 0.86 at 6 to 7 spicy days per week, ischemic heart disease 0.78 (95 percent CI 0.67 to 0.89), respiratory disease 0.71 (95 percent CI 0.62 to 0.81), with stronger associations for fresh chili than dried.

Real micronutrient contribution at culinary doses. 749 IU of vitamin A per teaspoon is not nothing for a spice.

Potential Negatives & Side Effects

Gastrointestinal distress is the dominant problem, and it is dose-dependent. In the Urbina 12-week trial, 23 percent of those originally enrolled in the 4 mg arm, 9 of 39, reported gastrointestinal distress and dropped out. The 2 mg arm reported no adverse events. That is a sharp threshold between 2 mg and 4 mg.

Unfavorable metabolic shifts at the higher oral dose. In that same trial the 4 mg group saw fasting insulin rise from 4.2 to 6.0 microunits per mL and HDL fall from 56.6 to 52.4 mg/dL, both p less than 0.05. A weight-management ingredient that lowers HDL and raises fasting insulin deserves skepticism.

Burning on topical application, with high dropout. This is why topical trials are hard to blind and why many use a 0.04 percent capsaicin control rather than a true placebo.

Worsening of anal fissure symptoms, documented above.

Contact dermatitis and ocular injury. Corneal abrasion is reported in approximately 7 percent of defense-spray exposures.

Aggravated cough on ACE inhibitors, and reduced nonheme iron absorption from fortified meals.

An unresolved gastric cancer signal at high intake. Pabalan and colleagues pooled 10 studies covering 2,452 cases and 3,996 controls in 2014. Low capsaicin intake carried an odds ratio of 0.55 (p equal to 0.003), medium-to-high intake 1.94 (p equal to 0.0004). Lopez-Carrillo’s 1994 case-control study of 220 cases and 752 controls in Mexico City found an odds ratio of 17.11 (95 percent CI 7.78 to 37.59) for high-level consumers versus nonconsumers, though no significant trend appeared when consumption was measured by daily frequency rather than self-rated intensity. These are case-control designs with recall problems, and they point opposite the Chinese cohort.

Deficiency Symptoms

Nobody has ever been short of cayenne. It is a spice rather than a required nutrient, so there is no requirement to fall below, no depletion syndrome, and no population that becomes unwell from eating no chili. The vitamin A and carotenoids in cayenne are supplied far more efficiently by foods eaten in larger quantities than a teaspoon of spice.

What cayenne addresses

• Localized neuropathic pain that has not responded to first-line systemic treatment
• Osteoarthritic and musculoskeletal joint pain in a specific accessible area
• Functional dyspepsia symptoms in patients who tolerate the first two weeks
• Mildly elevated LDL and total cholesterol, as one small contributor among several
• Appetite, marginally, at 4 mg of capsaicinoids daily and at the cost of a 23 percent dropout rate

Bottom line

Nothing goes wrong if you never take cayenne. Something may go right if you use it for one of the five problems above, and that applies most strongly to a cream or a patch rather than a capsule.

Toxicity Symptoms

At high intake

The German Federal Institute for Risk Assessment published Opinion 027/2024 on 21 June 2024 and declined to set a health-based guidance value, stating the data do not support deriving a specific dose above which symptoms occur. It did give an approximate dose-response picture: around 0.5 to 1 mg produces mild warmth and heartburn, around 170 mg pronounced adverse effects are expected, and at 600 mg and above severe symptoms requiring hospitalization are documented. A 515 mg cayenne capsule at 40,000 heat units holds roughly 1.3 mg of capsaicinoids, so 170 mg would take well over 100 capsules. Extreme-heat snack products and chili-eating challenges are the realistic route to those numbers.

Acute oral LD50 values are 148.1 mg/kg in female rats and 161.2 mg/kg in male rats, 97.4 mg/kg in female mice and 118.8 mg/kg in male mice, with dermal LD50 in mice above 512 mg/kg.

Signs to reduce or stop

• Severe epigastric pain, persistent nausea or vomiting after dosing
• Diarrhea or burning on defecation that does not settle within a few days
• Blistering, weeping or a burn that intensifies rather than fades at a topical site
• Rash, hives, swelling or breathing difficulty, an allergy question rather than a dose question
• New or worsening cough in someone taking an ACE inhibitor, or blood pressure rising after use

General note

Deaths are confined to extreme scenarios: aspiration and respiratory arrest after concentrated defense-spray exposure, and pediatric poisoning from ultra-hot snack products. Ordinary culinary and supplemental doses do not approach the toxic range, and the realistic harm from a cayenne capsule is a ruined stomach rather than an emergency.

How Cayenne Works

The receptor

Capsaicin binds TRPV1, the transient receptor potential vanilloid 1 channel, identified by Caterina and colleagues in Nature, 1997, under the title “The capsaicin receptor: a heat-activated ion channel in the pain pathway.” TRPV1 is a nonselective cation channel that also opens to noxious heat and low pH. Capsaicin opens it at body temperature, letting calcium and sodium into the nerve ending, which the brain reads as burning. Chili feels hot without producing heat because the molecule pulls a lever the nervous system reserves for thermal injury.

Defunctionalization, the therapeutic mechanism

Sustained or high-concentration TRPV1 activation causes calcium overload, depletion of neuropeptides including substance P, mitochondrial dysfunction and reversible retraction of epidermal nerve terminals. The nerve stops reporting. This is the reversible shutdown of one class of pain fiber rather than analgesia in the opioid sense, and recovery requires reinnervation, which is why Qutenza is dosed every 3 months.

Vasodilation and thermogenesis

TRPV1 activation releases calcitonin gene-related peptide, dilating local vessels. That is the redness and warmth at a topical site, and the real mechanism behind the folk framing of cayenne as a “circulatory” herb. It is local, not a systemic cardiovascular treatment. Separately, TRPV1 on gut vagal afferents feeds sympathetic outflow, raising catecholamine release and brown adipose activity, with small measured human effects.

Absorption and clearance

Roughly 50 to 90 percent of an oral dose is passively absorbed in the stomach, peaking in blood about 1 hour later. First-pass hepatic cytochrome P450 metabolism produces 16-hydroxycapsaicin, 17-hydroxycapsaicin, 16,17-dehydrocapsaicin, vanillin and vanillylamine, cleared renally. Topical half-life runs 1 to 24 hours. After Qutenza removal, plasma peaks near 4.6 ng/mL and most levels fall below the limit of quantitation within 3 to 6 hours.

Synergistic Supplements

Caffeine and green tea catechins. The thermogenic literature studies capsaicin alongside both, because the effect of any one alone is small. Combination protocols show larger energy expenditure changes than capsaicinoids alone, but the individual contributions have not been cleanly separated, and pooled results report anthropometric changes that would be unremarkable from diet alone.

Dietary fat. Not a supplement, but the most practical pairing. Capsaicin dissolves at 0.0013 g per 100 mL in water and readily in lipids, so a fat-containing meal improves dispersion and reduces mucosal burning.

Ginger. Formulated alongside cayenne in circulatory blends, with no controlled human trial of the combination. Traditional, not evidenced.

Topical menthol. Co-formulated in many OTC rubs. Menthol acts on TRPM8 rather than TRPV1, though combination products have not beaten single actives.

What does not belong here: nothing has been shown in humans to amplify capsaicin’s systemic effects. Stacking cayenne with other TRPV1 agonists adds burning, not benefit.

Interactions & What NOT to Take

ACE inhibitors. Capsaicin is documented to initiate or worsen the dry cough associated with an ACE inhibitor, and the interaction is plausible across the class. If a cough started with the ACE inhibitor, adding cayenne is the wrong experiment.

Cyclosporine and other CYP3A substrates. Capsaicin can modulate CYP3A, raising cyclosporine bioavailability with real risk of nephrotoxicity, hepatotoxicity and neurotoxicity. Transplant recipients should avoid supplemental cayenne.

P-glycoprotein substrates. Capsaicin modulates P-glycoprotein expression, altering absorption of drugs that depend on it. The mechanism is documented, the clinical magnitude is not.

Theophylline. Capsaicin may increase theophylline absorption, and theophylline has a narrow therapeutic index, so avoid rather than monitor.

Antiplatelet and anticoagulant drugs. Capsaicin has antiplatelet activity in vitro. No clinical bleeding events have been attributed to culinary or supplemental cayenne, but it belongs on a pre-surgical medication list.

Antihypertensives. The direction of effect is unsettled, and a systematic review found no net effect on blood pressure or heart rate.

Nonheme iron. Separate cayenne-heavy meals from iron supplements by a few hours.

Aspirin and NSAIDs. A single 20 g chili dose reduced aspirin-induced gastric injury in healthy volunteers, but chronic cayenne alongside chronic NSAIDs has not been studied.

Other oral drugs. Capsaicin-induced mucosal vasodilation can alter uptake of co-administered medications.

Quality, Testing & Adulteration

This category carries more documented fraud than almost any other botanical, because the raw material is a red powder sold by color and heat.

The powder frequently is not cayenne

Commercial cayenne powder is often a blend of pepper types, in many cases containing no cayenne peppers at all, and historically it was made largely from bird’s eye peppers. With no species requirement enforced on a spice or a supplement, “cayenne” on a label describes a heat class more than a cultivar.

Nonivamide spiking

Nonivamide occurs naturally in trace amounts and is manufactured cheaply at industrial scale. Adding it raises measured capsaicinoid content, and therefore the SHU number, without adding any Capsicum. USP and the European Pharmacopoeia cap it at 5.0 percent of total capsaicinoids, a specification that exists because the practice exists. A certificate of analysis reporting total capsaicinoids without breaking out nonivamide cannot rule it out.

Sudan dyes

Sudan I through IV are industrial azo dyes, banned in food, used to make faded chili powder and paprika look fresh. In February 2005, Sudan I traced to adulterated chili powder triggered what was then the largest food recall in UK history, reaching hundreds of products after the dye turned up in Premier Foods Worcestershire sauce. IARC places Sudan I in Group 3, not classifiable as to carcinogenicity in humans, but it is genotoxic in vitro and has no legal food use in the EU or US. FDA Import Alert 45-02 covers detention without physical examination of foods containing illegal or undeclared colors, citing sections 801(a)(3) and 721(a) of the Food, Drug, and Cosmetic Act.

Heavy metals, pathogens and mycotoxins

Consumer Reports tested 126 products across 38 brands in 2021. Roughly one third, 40 products, carried enough combined arsenic, lead and cadmium to concern children, and 31 exceeded the daily lead limit applied. Chili powder mostly performed well, paprika was mixed, and cayenne was not in the test set at all. FDA’s risk profile on spices found roughly 12 percent of imported shipments adulterated with filth such as insect fragments and animal hair, and 6.6 percent Salmonella prevalence. EU maximum levels for Capsicum spp. are 5 micrograms per kg aflatoxin B1, 10 micrograms per kg total aflatoxins, and 20 micrograms per kg ochratoxin A.

The SHU number is about to change without any pepper changing

At its 2026 annual meeting the American Spice Trade Association presented a correction to the capsaicin response factor in Method 21.3, expected to cut calculated total SHU by approximately 5.6 to 5.78 percent, with a proposed five-year implementation window. AOAC 995.03 uses about 15 SHU per microgram per gram, while the general industry convention, derived from pure capsaicin at 16,000,000 SHU, multiplies ppm by 16, a roughly 6 percent difference that depends only on which constant a lab chooses. A heat number is a calculation with a choice of constants inside it.

What to require of a supplier

• Total capsaicinoids in mg per serving, not heat units
• Individual capsaicin, dihydrocapsaicin and nordihydrocapsaicin figures, with nonivamide separate
• Method cited by number, AOAC 995.03 or ASTA 21.3, with the conversion factor stated
• Species and origin identification
• Heavy metals, aflatoxin B1 and total aflatoxins, ochratoxin A, and microbiological testing on the finished lot

Special Considerations

Pregnancy and lactation. Food amounts are the ceiling. Reported infant dermatitis following maternal consumption of red pepper-flavored foods argues against concentrated supplements, and the EU monograph requires a risk-benefit assessment for cutaneous use.

Children. The EU herbal monograph does not recommend cutaneous use under 18 years, and BfR flagged rising pediatric poisoning cases from extremely spicy snack products.

Surgery. Stop supplemental cayenne one to two weeks before scheduled surgery, given the in vitro antiplatelet activity and the post-hemorrhoidectomy data.

Irritable bowel syndrome. Capsaicin sensitizes visceral afferents, and patients with diarrhea-predominant IBS commonly report worse symptoms with chili.

People who already eat a lot of chili. A 2 mg capsaicinoid capsule adds nothing to a diet supplying 25 to 200 mg daily. The supplement is aimed at populations consuming 0.5 to 1.5 mg per day.

Defense spray exposure. Oleoresin capsicum is the same material. Flush eyes with copious water, do not rub, and seek evaluation for persistent visual symptoms, since corneal abrasion occurs in roughly 7 percent of exposures.

Storage. Capsaicinoids are reasonably heat-stable but the carotenoids giving cayenne its color are not. A powder gone brown has lost pigment, the condition that historically invited Sudan dye adulteration.

Research Status & Evidence Quality

Strong Evidence For

• Topical high-concentration capsaicin for postherpetic neuralgia. Backonja 2008, n equal to 402. Derry’s 2017 Cochrane review pooled 8 randomized studies totaling 2,488 patients.
• TRPV1 as the mechanism. Caterina 1997 in Nature is foundational and the receptor-level work is not in dispute.
• Acute gastroprotection against aspirin injury. Yeoh 1995, n equal to 18, injury score 1.5 versus 4.
• Worsening of acute anal fissure symptoms. Gupta 2008, n equal to 43, significantly higher pain and burning scores on chili.

Moderate Evidence For

• Lipid lowering in metabolic syndrome. Nine RCTs, 461 patients, LDL down 0.23 mmol/L.
• Reduced caloric intake at 4 mg capsaicinoids daily, 252 kcal per day below placebo at 12 weeks.
• Functional dyspepsia symptom reduction, emerging around week three.
• Low-concentration topical creams for osteoarthritic and musculoskeletal pain, where the effect is real but blinding is compromised by the burn.

Emerging / Preliminary Evidence For

• Population-level mortality associations. Hazard ratio 0.86 in 487,375 adults comes from a large cohort, but it measures spicy food frequency rather than capsaicinoid dose.
• Effects on the gut microbiome, studied mostly in mice at 40 to 60 mg/kg.
• Body composition and blood pressure. Jang’s 2020 meta-analysis of 11 RCTs in 609 participants found no effect on body weight (SMD minus 0.19, 95 percent CI minus 0.40 to 0.03, p equal to 0.09), BMI (p equal to 0.36), systolic pressure (SMD 0.22, p equal to 0.52) or diastolic pressure (SMD minus 0.16, p equal to 0.34), with only LDL reaching significance (SMD minus 0.39, p equal to 0.02).

Research Limitations

• The dose unit is inconsistent. The nine trials in the 2022 lipid meta-analysis spanned 2 mg to 3,200 mg daily, a 1,600-fold range, because some counted purified capsaicinoids and some fermented pepper paste. Pooling those produces a number describing no real product.
• Blinding is close to impossible. The high-concentration patch trials used a 0.04 percent capsaicin control, so every effect size is measured against an active comparator.
• The gastric cancer literature contradicts itself. Odds ratio 0.55 at low intake and 1.94 at medium-to-high intake across 2,452 cases and 3,996 controls, against a protective mortality association in a 487,375-person cohort.
• Nothing oral has been studied past 12 weeks under control. Cayenne capsules are sold for indefinite daily use with no long-term data.
• Products are not characterized the way trials are. A trial reporting 4 mg of capsaicinoids and a capsule reporting 100,000 heat units are not speaking the same language, and no regulation requires the translation.

Summary & Key Takeaways

Cayenne is a genuinely active botanical with a confused retail market. The pharmacology is mapped down to the receptor, the topical evidence is strong enough to have produced an FDA-approved prescription product, and the oral evidence supports a small set of modest effects at 2 mg to 6 mg of capsaicinoids per day. What breaks down is the link between that evidence and the bottle. Trials measure capsaicinoids in milligrams. Labels declare heat units, a derived figure descended from a 1912 tasting panel through HPLC conversion constants that differ by about 6 percent, and that the spice industry is preparing to revise downward by another 5.6 to 5.78 percent without a single pepper changing. A buyer holding a 515 mg capsule at 40,000 heat units is holding roughly 1.3 mg of capsaicinoids, and has to do the division to find out.

The gap between 2 mg and 4 mg daily is also where tolerability collapses: zero adverse events at 2 mg, 23 percent dropping out with gastrointestinal distress at 4 mg, plus a fall in HDL and a rise in fasting insulin. That is a narrow window for an ingredient sold as a metabolism booster.

Bottom Line

For localized nerve or joint pain, use a topical product with a stated capsaicin percentage three to five times daily for two to four weeks. For dyspepsia, roughly 2.5 g of red pepper powder daily has trial support, and the first two weeks will be unpleasant. For fat loss, 12 weeks at 4 mg daily did not change fat mass. And if the only number on the label is a heat unit figure, the product has told you how it would taste and nothing about what it delivers.

Key Safety Points

• Avoid with active anal fissure, broken skin, or known Capsicum allergy
• Avoid concentrated supplements in pregnancy and lactation, and cutaneous use under 18 years
• Do not apply external heat over a topical capsaicin product
• Separate from iron supplements, and avoid entirely with cyclosporine or theophylline
• Stop one to two weeks before surgery
• The 8 percent patch at 179 mg per patch is a clinician-applied prescription product, not a stronger cream

Special Note

Cayenne is among the most adulterated botanicals on the shelf, and the adulterations are specific and testable: pepper blends containing no cayenne, synthetic nonivamide inflating the heat figure, and Sudan dyes restoring the color of faded powder. Ask for total capsaicinoids in milligrams with nonivamide broken out, the method number and conversion factor used, plus heavy metal and aflatoxin results on the finished lot. A supplier who can only quote a Scoville number is quoting a taste estimate with a five-year revision already scheduled.